3 High-Yield Stocks to Buy Hand Over Fist in January

Core Insights - The S&P 500 index has a low dividend yield of 1.1%, making Procter & Gamble's (P&G) yield of 2.8% appear attractive for dividend investors [1] - Realty Income offers a high yield of 5.3% and has a history of increasing its monthly dividend for 30 years, supported by a strong balance sheet [2] - Pfizer has the highest yield among the three at 6.7%, but faces challenges due to upcoming patent expirations and recent failures in drug development [7] Group 1: Procter & Gamble - P&G is a major player in the consumer staples sector, focusing on higher-end markets, which is currently challenging due to economic pressures leading consumers to reduce spending [4] - The company experienced flat organic sales in Q2 of fiscal 2026, with a 1% volume decline offset by a 1% price increase, which is better than peers facing sales declines [5] - P&G's stock has decreased by approximately 15% from its 52-week high, potentially presenting a buying opportunity for long-term investors, and it is recognized as a Dividend King with over 60 years of annual dividend increases [5][6] Group 2: Realty Income - Realty Income's dividend yield stands at 5.3%, and it has a conservative management approach with a portfolio of over 15,500 properties [2] - The company has achieved a compound annual growth rate of 4.2% in dividends over the past 30 years, which aligns with or slightly exceeds inflation [2] Group 3: Pfizer - Pfizer's dividend yield is currently 6.7%, the highest among the discussed companies, but investor sentiment is low due to concerns over patent expirations and unsuccessful drug developments [7]